"After years of research, bringing a project to life as a clinical trial is incredibly energizing. Each trial represents progress, and each milestone is one step closer to getting potential new medicines to patients." Mollie helps our research teams turn promising science into clinical trials, so we can get new, effective and safe medicines to patients as quickly as possible. Read Mollie's Story here: https://lnkd.in/et-3RGzZ #CSL #PeoplePoweringScience
About us
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
- Website
-
https://www.csl.com/
External link for CSL
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Melbourne, Victoria
- Type
- Public Company
- Specialties
- Complex biologicals, vaccines, plasma and plasma derived therapeutics, biotechnology, and biopharma
Employees at CSL
Locations
-
Primary
Get directions
655 Elizabeth St
Melbourne, Victoria 3000, AU
-
Get directions
1020 1st Ave
King of Prussia, PA 19406, US
Updates
-
Each drop of plasma carries incredible therapeutic potential, and the next step on its extraordinary journey is fractionation. The third video in our #PlasmaSeries continues with Markus Ries. As Value Stream Lead overseeing and leading all fractionation activities at our Marburg, Germany site, he explains the scientific precision and state-of-the-art techniques CSL uses across our global facilities to transform plasma into life-changing therapies. Discover the science of saving lives in the video below and learn more here: https://bit.ly/4x5wwol #CSL #PlasmaDonation #PlasmaDerivedTherapies
-
What drives scientists to keep exploring the unknown? For Olga Neumueller, it starts with curiosity. At CSL, she works at the intersection of science, strategy and collaboration to help advance therapies that could make a meaningful difference for patients worldwide. Because discovery starts with asking the next question. Explore how you can make an impact at CSL: https://lnkd.in/dbhEc33c #PeoplePoweringScience #CSLCareers #Innovation #Research #CSLCareers #CSL
-
"When I was younger, I didn’t really understand the idea of purpose. Over time, that changed. I realised that even a small contribution can make someone’s life easier. There are many diseases that need treatment, and I hope that through innovation we can progress medicines that make life easier, if not cure diseases." Olga and her team work with health authorities to get new medicines to patients around the world. Read Olga's story here: https://lnkd.in/eXt5QmjQ #CSL #PeoplePoweringScience
-
What helps scientific discovery move faster? For Christine Rommel, it starts with connecting people, science and technology in smarter ways. At CSL, she helps researchers access the systems and data they need to collaborate more efficiently and focus on solving complex scientific challenges. Because when technology supports creativity, innovation can move faster. Explore careers at CSL: https://lnkd.in/dbhEc33c #PeoplePoweringScience #CSLCareers #Innovation #Research #PromisingFutures #CSL
-
What makes a strong CSL candidate? Curiosity, a commitment to collaboration and a strong sense of purpose are a good start. We’re looking for people inspired to innovate, solve complex challenges and help improve the lives of patients worldwide. Ready to grow your career alongside passionate teams and meaningful science? https://lnkd.in/gdJy4DQv #CSLCareers #EmployeeWellBeing #CSL
-
“At first, I wanted to become a medical doctor... but I realized that I wanted to be part of creating the solutions – contributing to new therapies, new drugs, new ways to help people." Christine is part of the team responsible for making sure CSL’s global network of scientists have access to the data they need to progress medicines efficiently and safely. Read Christine's story here: https://lnkd.in/dRN7U9-r #CSL #PeoplePoweringScience
-
Iron deficiency can quietly steal energy, focus and quality of life — and it’s a condition that is often missed or misunderstood. At CSL, we’re working to change that by raising awareness and delivering treatments that help people feel like themselves again. When you join CSL, you become part of a team that transforms lives through science and compassion. Ready to make an impact? csl.com/careers #CSL #CSLImpactReport #CSLCareers #PromisingFutures
-
-
What does it take to turn scientific potential into real-world therapies? For Alberto, it’s curiosity – and resilience. From early inspiration in genome research to helping advance projects from lab to development, his work is about moving science forward, step by step. Because every breakthrough starts with persistence. Ready to make a difference? Explore open R&D roles at CSL. https://lnkd.in/dbhEc33c #LifeSciences #Innovation #PeoplePoweringScience #CSLCareers #PromisingFutures #CSL
-
CSL’s Casarine Chong, General Counsel, R&D, Business Development and Strategy, joined a panel at #BIO2026 to share perspectives on navigating uncertainty and identifying opportunity in biotech dealmaking. This Bionews, Inc. feature captures key themes from the discussion shared by Cassie and her industry peers. If you are advancing vaccines or new therapies in immunology, hematology, cardiovascular & renal with the potential to change patient lives, CSL would welcome the opportunity to connect. We’re a $50 billion global biotech that invests $1.4 billion annually in R&D to deliver therapies and vaccines to people in over 100 countries. #CSL
Biotech dealmaking is gaining momentum at #BIO2026 - and this week’s conversations reflect it. Hear from Casarine Chong, General Counsel, R&D, Business Development and Strategy at CSL, and Jesse Shefferman, CEO of Protara Therapeutics, on staying nimble in an uncertain market and finding opportunity where others don’t. The full Bio.News feature also includes perspectives from Anamaria Sudarov, PhD (Managing Director at Wells Fargo), Chad Diehl, JD (Legal Team Lead, Licensing & Acquisitions and Alliance Management at Astellas Pharma), Joseph Lasaga (EVP and Chief Business Officer at Rigel Pharmaceuticals Inc.), and Austin Rory Hackett, M.D. (VP of Business Development at Innoviva). Read more on Bio.News: https://lnkd.in/eT_SQrkG